KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Other Non-Current Liabilities (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Other Non-Current Liabilities for 11 consecutive years, with $54.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Non-Current Liabilities rose 77.48% year-over-year to $54.5 million, compared with a TTM value of $54.5 million through Sep 2025, up 77.48%, and an annual FY2024 reading of $42.7 million, up 51.43% over the prior year.
  • Other Non-Current Liabilities was $54.5 million for Q3 2025 at Medpace Holdings, up from $51.9 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $54.5 million in Q3 2025 and bottomed at $16.1 million in Q3 2021.
  • Average Other Non-Current Liabilities over 5 years is $27.8 million, with a median of $23.0 million recorded in 2023.
  • The sharpest move saw Other Non-Current Liabilities rose 2.16% in 2021, then skyrocketed 82.07% in 2025.
  • Year by year, Other Non-Current Liabilities stood at $17.7 million in 2021, then grew by 27.93% to $22.7 million in 2022, then rose by 24.32% to $28.2 million in 2023, then soared by 51.43% to $42.7 million in 2024, then increased by 27.51% to $54.5 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for MEDP at $54.5 million in Q3 2025, $51.9 million in Q2 2025, and $53.0 million in Q1 2025.